Circumferential resection margin rates in esophageal cancer resection: oncological equivalency and comparable clinical outcomes between open versus minimally invasive techniques - a retrospective cohort study

被引:0
作者
Patel, Pranav H. [1 ]
Patel, Nikhil M. [1 ]
Doyle, Joseph P. [1 ]
Patel, Hina K. [1 ]
Alhasan, Yousef [1 ]
Luangsomboon, Alfa [1 ]
Petrou, Nikoletta [1 ]
Bhogal, Ricky H. [1 ,2 ]
Kumar, Sacheen [1 ,2 ,3 ]
Chaudry, Mohammed A. [1 ]
Allum, William H. [1 ]
机构
[1] Royal Marsden Hosp NHS Fdn Trust, Dept Upper GI Acad Surg, London SW1X 7HY, England
[2] Inst Canc Res, Upper Gastrointestinal Surg Oncol Res Grp, London SW1X 7HY, England
[3] Cleveland Clin London Hosp, Digest Dis & Surg Inst, Dept Upper GI Surg, London SW1X 7HY, England
关键词
esophageal cancer; cancer resection margin; esophagectomy; esophago-gastrectomy; laparoscopic surgery; surgical oncology; GASTROESOPHAGEAL JUNCTION; ESOPHAGOGASTRIC JUNCTION; OPEN-LABEL; PLUS CHEMOTHERAPY; ADENOCARCINOMA; INVOLVEMENT; SURVIVAL; CHEMORADIOTHERAPY; CLASSIFICATION; CAPECITABINE;
D O I
10.1097/JS9.0000000000001296
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background:Radical surgery for esophageal cancer requires macroscopic and microscopic clearance of all malignant tissue. A critical element of the procedure is achieving a negative circumferential margin (CRM) to minimize local recurrence. The utility of minimally invasive surgery poses challenges in replicating techniques developed in open surgery, particularly for hiatal dissection in esophago-gastrectomy. In this study, the technical approach and clinical and oncological outcomes for open and laparoscopic esophago-gastrectomy are described with particular reference to CRM involvement.Materials and methods:This cohort study included all patients undergoing either open or laparoscopic esophago-gastrectomy between January 2004 and June 2022 in a single tertiary center. A standard surgical technique for hiatal dissection of the esophago-gastric junction developed in open surgery was adapted for a laparoscopic approach. Clinical parameters, length of stay (LOS), postoperative complications, and mortality data were collected and analyzed by a Mann-Whitney U or Fisher's exact method.Results:Overall 447 patients underwent an esophago-gastrectomy in the study with 219 open and 228 laparoscopic procedures. The CRM involvement was 18.8% in open surgery and 13.6% in laparoscopic surgery. The 90-day-mortality for open surgery was 4.1 compared with 2.2% for laparoscopic procedures. Median Intensive care unit (ITU), inpatient LOS and 30-day readmission rates were shorter for laparoscopic compared with open esophago-gastrectomy (ITU: 5 versus 8 days, P=0.0004; LOS: 14 versus 20 days, P=0.022; 30-day re-admission 7.46 versus 10.50%). Postoperative complication rates were comparable across both cohorts. The rates of starting adjuvant chemotherapy were 51.8 after open and 74.4% in laparoscopic esophago-gastrectomy.Conclusion:This study presents a standardized surgical approach to hiatal dissection for esophageal cancer. The authors present equivalence between open and laparoscopic esophago-gastrectomy in clinical, oncological, and survival outcomes with similar rates of CRM involvement. The authors also observe a significantly shorter hospital length of stay with the minimally invasive approach.
引用
收藏
页码:6257 / 6267
页数:11
相关论文
共 55 条
[1]   Review of capecitabine as oral treatment of gastric, gastroesophageal, and Esophageal cancers [J].
Ajani, Jaffer .
CANCER, 2006, 107 (02) :221-231
[2]   Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Goetze, Thorsten O. ;
Meiler, Johannes ;
Kasper, Stefan ;
Kopp, Hans-Georg ;
Mayer, Frank ;
Haag, Georg Martin ;
Luley, Kim ;
Lindig, Udo ;
Schmiegel, Wolff ;
Pohl, Michael ;
Stoehlmacher, Jan ;
Folprecht, Gunnar ;
Probst, Stephan ;
Prasnikar, Nicole ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Trojan, Joerg ;
Koenigsmann, Michael ;
Martens, Uwe M. ;
Thuss-Patience, Peter ;
Egger, Matthias ;
Block, Andreas ;
Heinemann, Volker ;
Illerhaus, Gerald ;
Moehler, Markus ;
Schenk, Michael ;
Kullmann, Frank ;
Behringer, Dirk M. ;
Heike, Michael ;
Pink, Daniel ;
Teschendorf, Christian ;
Loehr, Carmen ;
Bernhard, Helga ;
Schuch, Gunter ;
Rethwisch, Volker ;
von Weikersthal, Ludwig Fischer ;
Hartmann, Joerg T. ;
Kneba, Michael ;
Daum, Severin ;
Schulmann, Karsten ;
Weniger, Joerg ;
Belle, Sebastian ;
Gaiser, Timo ;
Oduncu, Fuat S. ;
Guentner, Martina ;
Hozaeel, Wael ;
Reichart, Alexander .
LANCET, 2019, 393 (10184) :1948-1957
[3]   Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial [J].
Alderson, Derek ;
Cunningham, David ;
Nankivell, Matthew ;
Blazeby, Jane M. ;
Griffin, S. Michael ;
Crellin, Adrian ;
Grabsch, Heike I. ;
Langer, Rupert ;
Pritchard, Susan ;
Okines, Alicia ;
Krysztopik, Richard ;
Coxon, Fareeda ;
Thompson, Joyce ;
Falk, Stephen ;
Robb, Clare ;
Stenning, Sally ;
Langley, Ruth E. .
LANCET ONCOLOGY, 2017, 18 (09) :1249-1260
[4]   Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer [J].
Allum, William H. ;
Stenning, Sally P. ;
Bancewicz, John ;
Clark, Peter I. ;
Langley, Ruth E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5062-5067
[5]   Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis [J].
Angeramo, Cristian A. ;
Bras Harriott, Camila ;
Casas, Maria A. ;
Schlottmann, Francisco .
SURGERY, 2021, 170 (06) :1692-1701
[6]   Perioperative FLOT plus anti-PD-L1 avelumab (FLOT-A) in resectable oesophagogastric adenocarcinoma (OGA): Interim safety analysis results from the ICONIC trial. [J].
Athauda, Avani ;
Starling, Naureen ;
Chau, Ian ;
Cunningham, David ;
Watkins, David J. ;
Rao, Sheela ;
Kalaitzaki, Eleftheria ;
Bourmpaki, Elli ;
Davidson, Michael ;
Gillbanks, Angela ;
Lazaro-Alcausi, Retchel ;
Moneypenny, Michael ;
Begum, Ruwaida ;
von Loga, Katharina ;
Rana, Isma ;
Patel, Pranav ;
Doran, Sophie ;
Kumar, Sacheen ;
Chaudry, Asif ;
Gerlinger, Marco .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[7]  
Bancewicz J, 2002, LANCET, V359, P1727
[8]   KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer [J].
Bang, Yung-Jue ;
Van Cutsem, Eric ;
Fuchs, Charles S. ;
Ohtsu, Atsushi ;
Tabernero, Josep ;
Ilson, David H. ;
Hyung, Woo Jin ;
Strong, Vivian E. ;
Goetze, Thorsten Oliver ;
Yoshikawa, Takaki ;
Tang, Laura H. ;
Hwang, Peggy May Tan ;
Webb, Nancy ;
Adelberg, David ;
Shitara, Kohei .
FUTURE ONCOLOGY, 2019, 15 (09) :943-952
[9]   Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J].
Biere, Surya S. A. Y. ;
Henegouwen, Mark I. van Berge ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Rosman, Camiel ;
Roig Garcia, Josep ;
Gisbertz, Suzanne S. ;
Klinkenbijl, Jean H. G. ;
Hollmann, Markus W. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
van der Peet, Donald L. ;
Cuesta, Miguel A. .
LANCET, 2012, 379 (9829) :1887-1892
[10]   Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal Cancer? [J].
Brac, B. ;
Dufour, C. ;
Behal, H. ;
Vanderbeken, M. ;
Labreuche, J. ;
Leteurtre, E. ;
Mariette, C. ;
Eveno, C. ;
Piessen, G. ;
Renaud, F. .
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) :8337-8346